Feedback

Combined cellular and humoral immunity do not accelerate pRBC clearance.

  • Jasmin Akter (442379)
  • David S. Khoury (352987)
  • Rosemary Aogo (6407897)
  • Lianne I. M. Lansink (6407900)
  • Arya SheelaNair (6407903)
  • Bryce S. Thomas (3331143)
  • Pawat Laohamonthonkul (6407906)
  • Clara P. S. Pernold (6407909)
  • Matthew W. A. Dixon (1887931)
  • Megan S. F. Soon (3331152)
  • Lily G. Fogg (3331149)
  • Jessica A. Engel (6407912)
  • Trish Elliott (6407915)
  • Ismail Sebina (294665)
  • Kylie R. James (423666)
  • Deborah Cromer (282682)
  • Miles P. Davenport (68365)
  • Ashraful Haque (42437)
Open link
Publication date
March 2019
Icon DOI
10.1371/journal.ppat.1007599.g002
Publisher
Public Library of Science (PLoS)

Abstract

Py17XNL-immune and non-immune mice (n = 5/group) were transferred with CTFR+Py17XNL-infected pRBC, with peripheral RBC monitored at timepoints indicated for: (A) loss of Gen0 (CTFR+) pRBC over the first 25 hours, and (B) emergence over 3 days of Gen1+ (CTFR-) pRBC, with zoomed-in box showing the first 25 hours in more detail. All data representative of two independent experiments showing similar results.</p

Extracted data

We use cookies to provide a better user experience.
Data Protection